Clinical Trial News Archive - January 2018

January 3, 2018

Ardelyx Successfully Completes T3MPO-3 Safety Extension Study of Tenapanor for IBS-C

January 4, 2018

Shire Receives FDA Breakthrough Therapy Designation for Maribavir, an Investigational Treatment for Cytomegalovirus (CMV) Infection in Transplant Patients

January 8, 2018

AbbVie's Upadacitinib Granted Breakthrough Therapy Designation from the U.S. Food and Drug Administration for Atopic Dermatitis

January 22, 2018

Novartis Reports Erenumab Met All Primary and Secondary Endpoints in Unique Phase IIIb Study in Episodic Migraine Patients Who Have Failed Multiple Prior Preventive Treatments

January 24, 2018

GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce Publication of Landmark Epidiolex (cannabidiol) Study in The Lancet

January 26, 2018

AstraZeneca Reports Top-Line Phase III KRONOS Trial Results for PT010 Triple Combination Therapy in Chronic Obstructive Pulmonary Disease

January 28, 2018

Esketamine Phase 2 Data Published in JAMA Psychiatry Showed Significant Improvement of Depressive Symptoms in People with Treatment-Resistant Depression

January 30, 2018

Fexapotide BPH Phase 3 Clinical Trial Results Published in World Journal of Urology

January 31, 2018

Notification of the Results of the Phase III Clinical Study of HP-3070 (Transdermal Patch for the Treatment of Schizophrenia) in the U.S.

Clinical trial results archive

2023: January, February, March
2022: January, February, March, April, May, June, July, August, September, October, November, December
2021: January, February, March, April, May, June, July, August, September, October, November, December
2020: January, February, March, April, May, June, July, August, September, October, November, December
2019: January, February, March, April, May, June, July, August, September, October, November, December
2018: January, February, March, April, May, June, July, August, September, October, November, December
2017: May, June, July, August, September, October, November, December
2016: October

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Recently Approved

Daybue
Daybue (trofinetide) is a synthetic analog of the amino‐terminal tripeptide of I...
Zavzpret
Zavzpret (zavegepant) is a calcitonin gene-related peptide (CGRP) receptor...
Skyclarys
Skyclarys (omaveloxolone) is an activator of Nrf2 (nuclear factor erythroid...

More drug approvals

Subscribe to our newsletters